Orion Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Orion Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$98.98 - $115.74 $178,164 - $208,332	-1,800 Reduced 24.83%	5,450 $630,000
Q4 2022 Jan 20, 2023	SELL	$62.39 - $113.8 $59,270 - $108,110	-950 Reduced 11.59%	7,250 $0
Q3 2022 Oct 26, 2022	SELL	$58.92 - $84.67 $3,240 - $4,656	-55 Reduced 0.67%	8,200 $507,000
Q2 2022 Jul 22, 2022	SELL	$79.4 - $116.36 $79,400 - $116,360	-1,000 Reduced 10.8%	8,255 $658,000
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $17,284 - $21,962	200 Added 2.21%	9,255 $974,000
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $11,133 - $14,799	155 Added 1.74%	9,055 $833,000
Q4 2020 Feb 23, 2021	BUY	$67.0 - $84.39 $596,300 - $751,071	8,900 New	8,900 $651,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Capital Management LLC with notifications on news.